Dr Reddy’s Laboratories has informed that the Nomination, Governance & Compensation committee of the Board of Directors of the company has allotted 76,263 equity shares of Rs. 5 each of the company, fully paid up, on June 21, 2013, to Employees on exercise of their Stock Options as per the following details; 71,117 equity shares of Rs. 5 each pursuant to Dr. Reddy’s Employees Stock Option Scheme, 2002, and 5,146 equity shares of Rs. 5 each underlying 5,146 ADRs pursuant to Dr. Reddy’s Employees ADR Stock Option Scheme, 2007.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1872.60 |
| Dr. Reddys Labs. | 1376.30 |
| Cipla | 1453.50 |
| Zydus Lifesciences | 1121.65 |
| Lupin | 2407.45 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: